Ardelyx (ARDX)
(Delayed Data from NSDQ)
$6.15 USD
-0.07 (-1.13%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $6.16 +0.01 (0.16%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Ardelyx, Inc. [ARDX]
Reports for Purchase
Showing records 1 - 20 ( 190 total )
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
2Q Recap: Surprisingly Strong XPHOZAH Sales in Just Second Full Quarter Since Launch; Raise PT to $11
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Keeping Their Eyes On The Stars, Feet On The Ground Amidst Strong 2Q24
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
ARDX Strikes Back: Episode V -- Legal Challenge Filed
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Ardelyx''s Lawsuit Against CMS Creates Some Uncertainty, But We Still View ARDX Shares as Undervalued; Affirm Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Ardelyx, Inc.
Industry: Medical - Drugs
One Less Acronym To Worry About -- ARDX Says No To TDAPA
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Surprise Departure of Chief Commercial Officer Rodriguez Announced
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Ardelyx, Inc.
Industry: Medical - Drugs
Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology
Provider: Wedbush Securities Inc.
Analyst: CHICO L